GlycoMimetics Inc (NAS:GLYC) Stock News, Headlines & Updates
GlycoMimetics Inc Stock News from GuruFocus
- 1
Jun 04, 2024
GlycoMimetics Announces Comprehensive Results from Pivotal Phase 3 Study of Uproleselan in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)
Business Wire • 7:00am
May 29, 2024
GlycoMimetics to Host Key Opinion Leader Event to Review Comprehensive Results from Pivotal Phase 3 Study of Uproleselan in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) on June 4, 2024
Business Wire • 4:00pm
May 06, 2024
GlycoMimetics Announces Results of Pivotal Phase 3 Study of Uproleselan in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)
Business Wire • 6:00am
Apr 25, 2024
GlycoMimetics to Report First Quarter 2024 Financial Results on May 9, 2024
Business Wire • 7:00am
- 1
Show
Entries
Headlines
Total 0- 1
No recent news